Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2014 by Samsung Medical Center.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Ho Yeong Lim, Samsung Medical Center Identifier:
First received: November 9, 2011
Last updated: May 12, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)